Skip to main navigation Skip to search Skip to main content

Dose adherence and baseline exposure analysis of the ibrutinib 420 mg dose administered to patients with previously treated chronic lymphocytic leukemia (CLL).

  • Paul M. Barr
  • , Jennifer R. Brown
  • , Peter Hillmen
  • , Susan OBrien
  • , Jacqueline Claudia Barrientos
  • , Nishitha M. Reddy
  • , Steven Coutre
  • , Stephen P. Mulligan
  • , Ulrich Jäger
  • , Richard R. Furman
  • , Florence Cymbalista
  • , Marco Montillo
  • , Claire Dearden
  • , Tadeusz Robak
  • , Carol Moreno
  • , John Pagel
  • , Jan Andreas Burger
  • , Samuel Suzuki
  • , Danelle Frances James
  • , John C. Byrd

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
StatePublished - Jan 31 2017

Disciplines

  • Physical Therapy
  • Medicine and Health Sciences
  • Surgery

Cite this